Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2022-03-18 Sale | 2022-03-22 6:39 pm | Adamis Pharmaceuticals Corp | ADMP | Marguglio David J. SVP and Chief Business Officer | 11,859 | $0.6001 | $7,117 | 239,790 (Indirect Direct) | View |
2021-12-01 Sale | 2021-12-03 5:09 pm | Adamis Pharmaceuticals Corp | ADMP | Marguglio David J. SVP and Chief Business Officer | 50,757 | $0.785 | $39,844 | 264,649 (Indirect Direct) | View |
2020-11-20 Sale | 2020-11-24 4:29 pm | Adamis Pharmaceuticals Corp | ADMP | Marguglio David J. SVP and Chief Business Officer | 35,000 | $0.4 | $14,000 | 293,148 (Indirect Direct) | View |
2020-11-18 Sale | 2020-11-20 4:31 pm | Adamis Pharmaceuticals Corp | ADMP | Marguglio David J. SVP and Chief Business Officer | 8,532 | $0.4061 | $3,465 | 328,148 (Indirect Direct) | View |
2020-09-29 Sale | 2020-10-01 6:33 pm | Adamis Pharmaceuticals Corp | ADMP | Marguglio David J. SVP and Chief Business Officer | 20,000 | $0.8 | $16,000 | 314,423 (Indirect Direct) | View |
2020-08-18 Sale | 2020-08-20 5:41 pm | Adamis Pharmaceuticals Corp | ADMP | Marguglio David J. SVP and Chief Business Officer | 8,749 | $0.8741 | $7,648 | 334,423 (Indirect Direct) | View |
2020-05-18 Sale | 2020-05-20 4:09 pm | Adamis Pharmaceuticals Corp | ADMP | Marguglio David J. SVP and Chief Business Officer | 7,734 | $0.5601 | $4,332 | 343,172 (Indirect Direct) | View |
2020-03-18 Sale | 2020-03-19 6:40 pm | Adamis Pharmaceuticals Corp | ADMP | Marguglio David J. SVP and Chief Business Officer | 10,337 | $0.3366 | $3,479 | 330,906 (Indirect Direct) | View |
2020-02-24 Sale | 2020-02-26 6:01 pm | Adamis Pharmaceuticals Corp | ADMP | Marguglio David J. SVP and Chief Business Officer | 9,948 | $0.6035 | $6,004 | 341,243 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2022-02-14 5:16 pm | N/A N/A | Adamis Pharmaceuticals Corp | ADMP | Marguglio David J. SVP of Bus. Dev & CBO | 0 | $0 | 251,649 (Indirect) | View |
2021-12-09 Ownership | 2022-02-14 5:16 pm | N/A N/A | Adamis Pharmaceuticals Corp | ADMP | Marguglio David J. SVP of Bus. Dev & CBO | 13,000 | $0 | 251,649 (Direct) | View |
2021-02-21 Exercise | 2021-02-23 7:04 pm | N/A N/A | Adamis Pharmaceuticals Corp | ADMP | Marguglio David J. SVP and Chief Business Officer | 22,258 | $0 | 315,406 (Direct) | View |
2020-02-21 Ownership | 2021-02-16 7:50 pm | N/A N/A | Adamis Pharmaceuticals Corp | ADMP | Marguglio David J. SVP and Chief Business Officer | 22,257 | $0 | 315,406 (Direct) | View |
Ownership | 2021-02-16 7:50 pm | N/A N/A | Adamis Pharmaceuticals Corp | ADMP | Marguglio David J. SVP and Chief Business Officer | 0 | $0 | 315,406 (Indirect) | View |